HuidaGene Biotechnology Co., Ltd develops CRISPR-based gene-editing tools and therapies targeting genetic disorders in ophthalmology, neurology, and neuromuscular diseases. Their technology aims to repair genetic mutations responsible for life-threatening conditions, such as Duchenne Muscular Dystrophy and inherited retinal dystrophies.
Funding
Funding not disclosed
Founders
Product
Problem
Many genetic disorders, particularly those affecting the eye, brain, and muscles, lack effective treatments due to the difficulty of correcting the underlying genetic mutations. Traditional approaches often fail to address the root cause of these diseases, leaving patients with limited options.
Solution
HuidaGene Biotechnology develops gene-editing therapies using CRISPR technology to target and correct genetic mutations responsible for inherited diseases. Their pipeline focuses on ophthalmology, neurology, and neuromuscular disorders, offering potential cures for conditions like Duchenne Muscular Dystrophy (DMD), MECP2 Duplication Syndrome (MDS), Huntington's Disease (HD), Amyotrophic Lateral Sclerosis (ALS), _RPE65_-associated inherited retinal dystrophies (_RPE65_-IRD), neovascular age-related macular degeneration (nAMD), and RHO-associated retinitis pigmentosa (RHO-adRP). The company's approach aims to precisely edit disease-causing genes, restoring normal function and halting disease progression. Clinical trials are underway for several of their lead candidates.
Target Audience
The primary target audience includes patients suffering from genetic disorders such as Duchenne Muscular Dystrophy, inherited retinal dystrophies, and other neurological and neuromuscular diseases, as well as the physicians who treat them.
Features
- CRISPR/Cas13 RNA-editing platform for macular degeneration
- HG302 for Duchenne Muscular Dystrophy (DMD) is currently in the M.U.S.C.L.E. clinical trial
- HG204 for MECP2 Duplication Syndrome (MDS) is currently in the HERO clinical trial
- Multiple R&D pipelines targeting ophthalmology and neurology indications